Literature DB >> 9054223

Therapeutic uses of botulinum toxin.

A H Wheeler1.   

Abstract

Botulinum toxin was introduced as a safe and effective treatment for strabismus and other disorders of the extraocular muscles in the early 1980s. Approved by the U.S. Food and Drug Administration for use in the treatment of strabismus, blepharospasm and seventh cranial nerve disorders, botulinum toxin has also been shown to be effective in the treatment of a wide range of disorders associated with involuntary muscle contraction and spasm, including focal dystonia, hemifacial spasm and spasmodic torticollis. Neurologic syndromes associated with excessive muscle contraction or involuntary movement, disturbances of sphincter function and musculoskeletal pain are other conditions that can be successfully treated with botulinum toxin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054223

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  2 in total

Review 1.  Myofascial pain disorders: theory to therapy.

Authors:  Anthony H Wheeler
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Botulinum toxin type A enhances the inhibitory spontaneous postsynaptic currents on the substantia gelatinosa neurons of the subnucleus caudalis in immature mice.

Authors:  Seon-Hui Jang; Soo-Joung Park; Chang-Jin Lee; Dong-Kuk Ahn; Seong-Kyu Han
Journal:  Korean J Physiol Pharmacol       Date:  2018-08-27       Impact factor: 2.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.